Vicki L. Sato, Director at Vir Biotechnology, Inc. (VIR), sold 44,000 shares at $5.10 ($224K) on 2025-07-01, disclosed to the SEC on 2025-07-02.
Scheduled sale ($224k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.10 | 22,000 | $112K | 50.0% |
| 2 | $5.10 | 22,000 | $112K | 50.0% |
| Total | $5.10 avg | 44,000 | $224K | 100% |
| Filing → |
| VIR | SELL | 2026-03-03 | $416K | — | Filing → |
| VIR | SELL | 2026-02-26 | $825K | — | Filing → |
| VIR | SELL | 2026-02-03 | $170K | — | Filing → |